SARS-CoV-2 animal vaccine with cross-protection against Wuhan strain and delta variant.

ABSTRACT: The increasing number of reverse zoonotic transmission cases, in which pathogens are transmitted from humans to companion animals, has raised substantial concerns in both veterinary and public health fields. The emergence of novel viral strains through interspecies transmission poses a potential threat to the health of animals and humans. In response to the growing incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in companion animals, a SARS-CoV-2 vaccine candidate was developed and evaluated for use in these species to mitigate the risks associated with viral transmission. The Delta variant (B.1.617.2) of SARS-CoV-2 emerged as one of the most concerning variants during the COVID-19 pandemic due to its heightened transmissibility, increased pathogenicity

SUBMITTER: Ga E 

PROVIDER: S-EPMC12727877 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature